Amend SB 1326 (House Committee Report) as follows: (1) On page 6, between line 6 and line 7, insert new SECTION 13, as follows: SECTION 13. Chapter 104, Subchapter B, Health and Safety Code, is amended by adding new Section 104.0157, to read as follows: Sec. 104.0157. TEXAS HEALTH BENEFITS STUDY. (a) The statewide health coordinating council, in consultation with all interested parties, shall study the disparity in patient co-payments between orally- and intravenously- administered chemotherapies, the reasons for the disparity, and the patient benefits in establishing co-payment parity between oral and infused chemotherapy agents. (b) Not later that August 1, 2010, the council shall submit to the governor, the lieutenant governor, the speaker of the house of representatives, and the appropriate standing committees of the legislature a report regarding the results of the study conducted under Subsection (a), together with any recommendation for legislation. (2) Renumber the remaining section of the bill as appropriate.